THE introduction of sulfa drugs in 1937, at the time I completed my residency in otolaryngology, seemed to point toward the end of surgery for much of the suppurative diseases in this field. The senior specialists ominously predicted the early demise of our specialty because they believed that these drugs would control surgical suppurative diseases and that general surgeons would annex all tumor surgery of the head and neck region.
In the light of this background, the younger otolaryngologists viewed with considerable interest Lempert's earliest publication of a one-stage fenestration operation for improving hearing in clinical otosclerosis. After the usual initial objection to a new, revolutionary surgical technique, there was gradual acceptance when favorable results were increasingly reported.
Interest in his endaural approach to surgery for otosclerosis as well as tympanomastoid disease became worldwide. He soon established a course in temporal-bone dissection and observation of surgery to teach this new
Juers AL. Julius Lempert: His Legacy to Otology. Arch Otolaryngol. 1969;90(6):700–701. doi:10.1001/archotol.1969.00770030702008
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: